Literature DB >> 12418470

Somatostatin receptor scintigraphy using (99m)Tc-EDDA/HYNIC-TOC in graves' disease.

Michael Gabriel1, Clemens Decristoforo, Roy Moncayo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12418470     DOI： 10.1007/s00259-002-0927-x

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  3 in total

1.  Somatostatin receptor expression in the thyroid demonstrated with 111In-octreotide scintigraphy.

Authors:  W Becker; U Schrell; M Buchfelder; J Hensen; J Wendler; M Gramatzki; F Wolf
Journal:  Nuklearmedizin       Date:  1995-06       Impact factor: 1.379

2.  99mTc-EDDA/HYNIC-TOC: a new 99mTc-labelled radiopharmaceutical for imaging somatostatin receptor-positive tumours; first clinical results and intra-patient comparison with 111In-labelled octreotide derivatives.

Authors:  C Decristoforo; S J Mather; W Cholewinski; E Donnemiller; G Riccabona; R Moncayo
Journal:  Eur J Nucl Med       Date:  2000-09

3.  Evaluation of immunological mechanisms mediating thyroid-associated ophthalmopathy by radionuclide imaging using the somatostatin analog 111In-octreotide.

Authors:  R Moncayo; I Baldissera; C Decristoforo; D Kendler; E Donnemiller
Journal:  Thyroid       Date:  1997-02       Impact factor: 6.568
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.